Ilan Shimon

Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial

Stefano Del Prato, Steven E. Kahn, Imre Pávó et al. · The Lancet · 2021 · 642 citations

Medicine, Pharmacology, Pharmacotherapy +16

Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomised, phase 3 trial

Mônica R. Gadelha, Marcello D. Bronstein, Thierry Brue et al. · The Lancet Diabetes & Endocrinology · 2014 · 402 citations

Medicine, Endocrinology, Pharmacotherapy +4

A Consensus on the Diagnosis and Treatment of Acromegaly Comorbidities: An Update

Andrea Giustina, Ariel Barkan, Albert Beckers et al. · The Journal of Clinical Endocrinology & Metabolism · 2019 · 364 citations · Full text

Medicine, Clinical Sciences, Endocrinology +9

Low Albumin Levels Are Associated with Mortality Risk in Hospitalized Patients

Amit Akirov, Hiba Masri‐Iraqi, Alaa Atamna et al. · The American Journal of Medicine · 2017 · 354 citations · Full text

Medicine, Internal Medicine, Clinical Medicine +12

Somatostatin receptor subtype specificity in human fetal pituitary cultures. Differential role of SSTR2 and SSTR5 for growth hormone, thyroid-stimulating hormone, and prolactin regulation.

Ilan Shimon, John E. Taylor, J. Z. Dong et al. · Journal of Clinical Investigation · 1997 · 312 citations · Full text

Medicine, Biochemistry, Endocrinology +17